Skip to main content

Cartilage erosion in rheumatoid arthritis: studies in SCID mouse model

  • Chapter
Gene Therapy in Inflammatory Diseases

Part of the book series: Progress in Inflammation Research ((PIR))

  • 80 Accesses

Abstract

In the past few years there has been a growing interest in gene therapy to be used not only for the treatment of inherited, but also acquired, diseases. Although genetic factors have been frequently implicated in the pathogenesis of rheumatoid arthritis (RA) [1], and recent reports suggest mutations of tumor suppressor genes to play a role [2], RA is not caused by a specific genetic mutation. Much more likely it is an acquired disorder with a complex pathogenesis and yet unknown etiology. Gene therapy approaches in diseases such as RA differ from those in defined genetic disorders. Apart from the problem of how to correct a specific genetic abnormality, in RA another question appears to be crucial: that of which pathogenic pathway to modulate. Therefore, a suitable animal model for gene therapy approaches in RA should not only reflect relevant features of human disease but also permit one to analyze alterations in key disease processes as closely as possible to the conditions found in people.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Weyand CM, Goronzy JJ (1997) Pathogenesis of rheumatoid arthritis. Med Clin N Am 81: 29–55

    Article  PubMed  CAS  Google Scholar 

  2. Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR (1997) Somatic mutations in the p53 suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 94: 10895–10900

    Article  PubMed  CAS  Google Scholar 

  3. Gay S, Gay RE, Koopman WJ (1993) Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis. Ann Rheum Dis 52: S39–S

    Article  PubMed  Google Scholar 

  4. Firestein GS (1996) Invasive fibroblast-like synoviocytes in rheumatoid arthritis-passive responders or transformed aggressors. Ann Rheum Dis 39: 1781–1790

    CAS  Google Scholar 

  5. Fassbender HG (1983) Histomorphologic basis of articular cartilage destruction in rheumatoid arthritis. Coll Relat Res 3: 141–155

    Article  PubMed  CAS  Google Scholar 

  6. Lafyatis R, Remmers EF, Roberts AB, Yocum DE, Sporn MB, Wilder RL (1989) Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest 83: 1267–1276

    Article  PubMed  CAS  Google Scholar 

  7. Müller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, Gay S (1996) Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 149: 1607–1615

    PubMed  Google Scholar 

  8. Trabandt A, Gay RE, Fassbender HG, Gay S (1991) Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arthritis Rheum 34: 1444–1451

    Article  PubMed  CAS  Google Scholar 

  9. Firestein GS, Paine MM (1992) Expression of stromelysin and TIMP in rheumatoid arthritis synovium. Am J Pathol 140: 1309–1314

    PubMed  CAS  Google Scholar 

  10. Hummel KM, Petrow PK, Jeisy E, Franz J, Gay RE, Brömme D, Gay S (1997) Cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis (RA) at sites of bone destruction. Arthritis Rheum 40: S250(Abstract)

    Google Scholar 

  11. Petrow PK, Hummel KM, Franz J, Kriegsmann J, Müller-Ladner U, Gay RE, Gay S (1997) In situ-detection of MMP13 messenger RNA in the synovial membrane and cartilage-pannus junction in rheumatoid arthritis. Arthritis Rheum 40: S336(Abstract)

    Google Scholar 

  12. Mort JS, Dodge GR, Roughley PJ, Liu J, Finch SJ, DiPasquale G, Poole AR (1993) Direct evidence for active metalloproteinase mediating matrix degradation in inter-leukin-1 stimulated human articular cartilage. Matrix 13: 95–102

    Article  PubMed  CAS  Google Scholar 

  13. Okada Y, Konomi H, Yada T, Kimata K, Nagase H (1989) Degradation of type IX collagen by matrix metalloproteinase 3 (stromelysin) from human rheumatoid synovial cells. FEBS Lett 244: 473–476

    Article  PubMed  CAS  Google Scholar 

  14. Ahrens D, Koch AE, Pope RM, Stein-Picarella M, Niedbala MJ (1996) Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 39: 1576–1587

    Article  PubMed  CAS  Google Scholar 

  15. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, Salvesen G, Nagase H (1990) Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem 194: 721–730

    Article  PubMed  CAS  Google Scholar 

  16. Okada Y, Nagase H, Harris ED Jr (1987) Matrix metalloproteinases 1, 2, and 3 from rheumatoid synovial cells are sufficient to destroy joints. J Rheumatol 14: 41–42

    PubMed  CAS  Google Scholar 

  17. Hiraoka K, Sasaguri Y, Komiya S, Inoue A, Morimatsu M (1992) Cell proliferation-related production of matrix metalloproteinases 1 (tissue collagenase) and 3 (stromelysin) by cultured human rheumatoid synovial fibroblasts. Biochem Int 27: 1083–1091

    PubMed  CAS  Google Scholar 

  18. Sorsa T, Konttinen YT, Lindy O, Ritchlin C, Saari H, Suomalainen K, Eklund KK, Santavirta S (1992) Collagenase in synovitis of rheumatoid arthritis. Semin Arthritis Rheum 22: 44–53

    Article  PubMed  CAS  Google Scholar 

  19. Xue C, Takahashi M, Hasunuma T, Aono H, Yamamoto K, Yoshino S, Sumida T, Nishioka K (1997) Characterisation of fibroblast-like cells in pannus lesions of patients with rheumatoid arthritis sharing properties of fibroblasts and chondrocytes. Ann Rheum Dis 56: 262–267

    Article  PubMed  CAS  Google Scholar 

  20. Keyszer GM, Heer AH, Kriegsmann J, Geiler T, Trabandt A, Keysser M, Gay RE, Gay S (1995) Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis by in situ hybridization. Arthritis Rheum 38: 976–984

    Article  PubMed  CAS  Google Scholar 

  21. Dayer JM, Beutler B, Cerami A (1985) Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 162: 2163–2168

    Article  PubMed  CAS  Google Scholar 

  22. Dayer JM, de Rochemonteix B, Burrus B, Demczuk S, Dinarello A (1986) Human recombinant interleukin-1 stimulates collagenase and protaglandin E2 production by human synovial cells. J Clin Invest 77: 86

    Article  Google Scholar 

  23. Lemaire R, Huet G, Zerimech F, Grard G, Fontaine C, Duquesnoy B, Flipo RM (1997) Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells. Br J Rheumatol 36: 735–743

    Article  PubMed  CAS  Google Scholar 

  24. Firestein GS, Zvaifler NJ (1997) Anticytokine therapy in rheumatoid arthritis. N Engl J Med 337: 195–197

    Article  PubMed  CAS  Google Scholar 

  25. Migita K, Eguchi K, Kawabe Y, Ichinose Y, Tsukada T, Aoyagi T, Nakamura H, Nagataki S (1996) TNF-alpha-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts. Immunology 89: 553–557

    Article  PubMed  CAS  Google Scholar 

  26. Alvaro Gracia JM, Zvaifler NJ, Brown CB, Kaushansky K, Firestein GS (1991) Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-alpha. J Immunol 146: 3365–3371

    PubMed  CAS  Google Scholar 

  27. Remmers EF, Lafyatis R, Kumkumian GK, Case JP, Roberts AB, Sporn MB, Wilder RL (1990) Cytokines and growth regulation of synoviocytes from patients with rheumatoid arthritis and rats with streptococcal cell wall arthritis. Growth Factors 2: 179–188

    PubMed  CAS  Google Scholar 

  28. O’SulliVan FX, Gay RE, Gay S (1995) Spontaneous arthritis models. In: B Henderson, JCW Edwards, ER Pettipher (eds): Mechanisms and models in theumatoid arthritis. Academic Press, London, 471–483

    Chapter  Google Scholar 

  29. Bosma GC, Custer RP, Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301: 527–530

    Article  PubMed  CAS  Google Scholar 

  30. Vladutiu AO (1993) The severe combined immunodeficient (SCID) mouse as a model for the study of autoimmune diseases. Clin Exp Immunol 93: 1–8

    Article  PubMed  CAS  Google Scholar 

  31. Mosier DE, Gulizia RJ, Baird SM, Wilson DB (1988) Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335: 256–259

    Article  PubMed  CAS  Google Scholar 

  32. Tighe H, Silverman GJ, Kozin F, Tucker R, Gulizia R, Peebles C, Lotz M, Rhodes G, Machold K, Mosier DE et al (1990) Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cell from rheumatoid arthritis patients. Eur J Immunol 20: 1843–1848

    Article  PubMed  CAS  Google Scholar 

  33. Brinckerhoff CE, Harris ED (1981) Survival of rheumatoid synovium implanted into nude mice. Am J Pathol 103: 411–419

    PubMed  CAS  Google Scholar 

  34. Adams CD, Zhou T, Mountz JD (1990) Transplantation of human rheumatoid synovium into a SCID mouse as a model for disease activity. Arthritis Rheum 33: S120(Abstract)

    Google Scholar 

  35. Rendt KE, Barry TS, Jones DM, Richter CE, McCachren SS, Haynes BF (1991) An in vivo model of human rheumatoid arthritis (RA) using RA synovium engrafted into severe combined immune-deficient (SCID) mice. FASEB J 5: 1371(Abstract)

    Google Scholar 

  36. Rendt KE, Barry TS, Jones DM, Richter CE, McCachren SS, Haynes BF (1993) Engraftment of human synovium into severe combined deficient (SCID) mice: migration of human peripheral blood T-cells to engrafted human synovium and to mouse lymph nodes. J tImmunol 151: 7324–7336

    CAS  Google Scholar 

  37. Geiler T, Kriegsmann J, Keyszer GM, Gay RE, Gay S (1994) A new model for rheuma toid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice. Arthritis Rheum 37: 1664–1671

    Article  PubMed  CAS  Google Scholar 

  38. Bosma GC, Fried M, Custer RP, Carroll A, Bosma MJ (1988) Evidence of functional lymphocytes in some (leaky) scid mice. N Engl J Med 167: 1016–1033

    CAS  Google Scholar 

  39. Müller-Ladner U, Roberts CR, Franklin BN, Gay RE, Robbins PD, Evans CH, Gay S (1997) Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol 158: 3492–3498

    PubMed  Google Scholar 

  40. Kriegsmann J, Müller-Ladner U, Gay RE, Gay S (1997) Molecular immunopathology. In: LA Herzenberg, C Blackwell, D Weir (eds): The handbook of experimental immunology. 133. 1-133.16

    Google Scholar 

  41. Kriegsmann J, Keyszer GM, Geiler T, Bräuer R, Gay RE, Gay S (1993) Expression of vascular cell adhesion molecule-1 mRNA and protein in rheumatoid arthritis synovium demonstrated by in situ hybridization and immunohistochemistry. Lab Invest 68: 682–688

    Google Scholar 

  42. Firestein GS, Alvaro Gracia JM, Maki R (1990) Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 144: 3347–3353

    PubMed  CAS  Google Scholar 

  43. Henderson B, Pettipher ER (1989) Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol 75: 306–

    PubMed  CAS  Google Scholar 

  44. Harigai M, Hara M, Kitani A, Norioka K, Hirose T, Hirose W, Suzuki K, Kawakami M, Masuda K, Shinmei M et al (1991) Interleukin 1 and tumor necrosis factor-alpha synergistically increase the production of interleukin 6 in human synovial fibroblast. J Clin Lab Immunol 34: 107–113

    PubMed  CAS  Google Scholar 

  45. Arend WP (1993) Interleukin-1 receptor antagonist. Adv Immunol 54: 167–227

    Article  PubMed  CAS  Google Scholar 

  46. Berger AE, Carter DB, Hankey SO, McEwan RN (1993) Cytokine regulation of the interleukin-1 receptor antagonist protein in U937 cells. Eur J Immunol 23: 39–45

    Article  PubMed  CAS  Google Scholar 

  47. Firestein GS, Boyle DL, Yu C, Paine MM, Whisenand TD, Zvaifler NJ, Arend WP (1994) Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 37: 644–652

    Article  PubMed  CAS  Google Scholar 

  48. Chikanza IC, Roux-Lombard P, Dayer JM, Panayi GS (1995) Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis: Pathogenetic implications. Arthritis Rheum 38: 642–648

    Article  PubMed  CAS  Google Scholar 

  49. Brennan FM, Maini RN, Feldmann M (1992) TNF alpha-a pivotal role in rheumatoid arthritis. Br J Rheumatol 31: 293–298

    Article  PubMed  CAS  Google Scholar 

  50. Borden P, Heller RA (1997) Transcriptional control of matrix metalloproteinases and the tissue inhibitor of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr 7: 159–178

    Article  PubMed  CAS  Google Scholar 

  51. Dayer JM, Burger D (1994) Interleukin-1, tumor necrosis factor and their specific inhibitors. Eur Cytokine Netw 5: 563–571

    PubMed  CAS  Google Scholar 

  52. Probert L, Plows D, Kontogeorgos G, Kollias G (1995) The type 1 interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF transgenic mice. Eur J Immunol 25: 1794–1797

    Article  PubMed  CAS  Google Scholar 

  53. Weckmann AL, Alcocer Varela J (1996) Cytokine inhibitors in autoimmune disease. Semin Arthritis Rheum 26: 539–557

    Article  PubMed  CAS  Google Scholar 

  54. Williams RO, Ghrayeb J, Feldmann M, Maini RN (1995) Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4. Immunology 84: 433–439

    PubMed  CAS  Google Scholar 

  55. Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K et al (1997) treatment of rheumatoid arthritis with recombinant human tumor necrosis factor receptor (p75)-Fc-fusion protein. N Engl J Med 337: 141–147

    Article  PubMed  CAS  Google Scholar 

  56. Geng Y, Gulbins E, Altman A, Lotz M (1994) Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proc Natl Acad Sci USA 91: 8602–8606

    Article  PubMed  CAS  Google Scholar 

  57. Maini RN, Elliott M, Brennan FM, Williams RO, Feldmann M (1997) TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis. APMIS 105: 257–263

    Article  PubMed  CAS  Google Scholar 

  58. Evans CH, Robbins PD, Ghivizzani SC, Herndon JH, Kang R, Bahnson AB, Barranger JA, Elders EM, Gay S, Tomaino MM et al (1996) Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 7: 1261–1280

    Article  PubMed  CAS  Google Scholar 

  59. Evans CH, Robbins PD (1996) Pathways to gene therapy in rheumatoid arthritis. Curr Opin Rheumatol 8: 230–234

    Article  PubMed  CAS  Google Scholar 

  60. Nita I, Ghivizzani SC, Galea Lauri J, Bandara G, Georgescu HI, Robbins PD, Evans CH (1996) Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo. Arthritis Rheum 39: 820–

    Article  PubMed  CAS  Google Scholar 

  61. Müller-Ladner U, Franklin BN, Roberts CR, Gay RE, Robbins PD, Evans CH, Gay S (1996) Gene transfer of interleukin-10 into human synovial fibroblasts and implantation into the SCID mouse. Arthritis Rheum 39: S160 (Abstract)

    Google Scholar 

  62. Müller-Ladner U, Roberts CR, Franklin BN, Gay RE, Robbins PD, Evans, CH, Gay S (1996) Gene transfer of TNF-alpha receptor p55 into human synovial fibroblasts and implantation into the SCID mouse. Arthritis Rheum 39: S307 (Abstract)

    Google Scholar 

  63. Trabandt A, Aicher WK, Gay RE, Sukhatme VP, Fassbender HG, Gay S (1992) Spontaneous expression of immediately-early response genes c-fos and egr-1 in collagenase-producing rheumatoid synovial fibroblasts. Rheumatol Int 12: 53–59

    Article  PubMed  CAS  Google Scholar 

  64. Hummel KM, Petrow PK, Nawrath M, Müller-Ladner U, Neidhart M, Pavlovic J, Gay RE, Möiling K, Gay S (1997) Retroviral gene transfer of a c-Raf dominant negative mutant does not inhibit synovial fibroblasts (SF) from patients with rheumatoid arthritis (RA) to invade normal human cartilage in the SCID mouse model. Arthritis Rheum 40: S120 (Abstract)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Basel AG

About this chapter

Cite this chapter

Pap, T., Müller-Ladner, U., Hummel, K.M., Gay, R.E., Gay, S. (2000). Cartilage erosion in rheumatoid arthritis: studies in SCID mouse model. In: Evans, C.H., Robbins, P.D. (eds) Gene Therapy in Inflammatory Diseases. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8478-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8478-5_3

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9584-2

  • Online ISBN: 978-3-0348-8478-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics